EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Data up to Jan 2025
Total Citations Per Year
Abstract
References (24)
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
2004 • 11,185 citations
Use of Chemotherapy plus a Monoclonal Antibody against HER2 for Metastatic Breast Cancer That Overexpresses HER2
2001 • 11,070 citations
Mutations of the BRAF gene in human cancer
2002 • 10,249 citations
Efficacy and Safety of Imatinib Mesylate in Advanced Gastrointestinal Stromal Tumors
2002 • 4,254 citations
Cancer Statistics, 2004
2004 • 4,026 citations
High Frequency of Mutations of the PIK3CA Gene in Human Cancers
2004 • 3,304 citations
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 • 2,874 citations
Activity of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in the Blast Crisis of Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia with the Philadelphia Chromosome
2001 • 2,749 citations
Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer
2003 • 2,522 citations
Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor
2003 • 2,216 citations
Gefitinib in Combination With Gemcitabine and Cisplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 1
2004 • 1,733 citations
Gefitinib in Combination With Paclitaxel and Carboplatin in Advanced Non–Small-Cell Lung Cancer: A Phase III Trial—INTACT 2
2004 • 1,723 citations
The Conformational Plasticity of Protein Kinases
2002 • 1,691 citations
Structure of the Epidermal Growth Factor Receptor Kinase Domain Alone and in Complex with a 4-Anilinoquinazoline Inhibitor
2002 • 1,308 citations
Bronchioloalveolar Pathologic Subtype and Smoking History Predict Sensitivity to Gefitinib in Advanced Non–Small-Cell Lung Cancer
2004 • 749 citations
Mutational Analysis of the Tyrosine Kinome in Colorectal Cancers
2003 • 487 citations
Differential expression of the epidermal growth factor receptor and its ligands in primary non-small cell lung cancers and adjacent benign lung.
1993 • 482 citations
Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results
2001 • 359 citations
Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation
2004 • 307 citations
Missense mutations of the BRAF gene in human lung adenocarcinoma.
2002 • 283 citations
Amplification of the structurally and functionally altered epidermal growth factor receptor gene (c-erbB) in human brain tumors.
1988 • 218 citations
Outcomes of patients with advanced non-small cell lung cancer treated with gefitinib (ZD1839, ‘Iressa’) on an expanded access study
2004 • 198 citations
Opportunities and challenges in the development of kinase inhibitor therapy for cancer
2003 • 171 citations
Sensitivity of Non-Small-Cell Lung Cancer Cell Lines Established from Patients Treated with Prolonged Infusions of Paclitaxel
2003 • 17 citations
Cited By (0)
No citing papers found in database